Edition:
United States

Clementia Pharmaceuticals Inc (CMTA.OQ)

CMTA.OQ on NASDAQ Stock Exchange Global Select Market

15.62USD
22 Jun 2018
Change (% chg)

$1.21 (+8.40%)
Prev Close
$14.41
Open
$14.32
Day's High
$16.00
Day's Low
$14.32
Volume
16,501
Avg. Vol
14,822
52-wk High
$20.12
52-wk Low
$11.77

Latest Key Developments (Source: Significant Developments)

Clementia Pharmaceuticals Reports Qtrly Loss Per Share Of $0.42
Wednesday, 9 May 2018 06:30am EDT 

May 9 (Reuters) - Clementia Pharmaceuticals Inc ::CLEMENTIA REPORTS FIRST QUARTER 2018 OPERATING RESULTS AND PIPELINE UPDATES.CLEMENTIA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.42.CLEMENTIA PHARMACEUTICALS INC - AS OF MARCH 31, 2018, CLEMENTIA HAD CASH AND INVESTMENTS OF $131.6 MILLION..  Full Article

Clementia Pharmaceuticals Inc Q4 2017 Loss Per Share $0.37
Wednesday, 28 Feb 2018 04:05pm EST 

Feb 28 (Reuters) - Clementia Pharmaceuticals Inc ::Q4 2017 LOSS PER SHARE $0.37.Q4 EARNINGS PER SHARE VIEW $-0.35 -- THOMSON REUTERS I/B/E/S.  Full Article

Clementia Initiates Pivotal Phase 3 MOVE Trial For Palovarotene
Tuesday, 12 Dec 2017 06:30am EST 

Dec 12 (Reuters) - Clementia Pharmaceuticals Inc ::CLEMENTIA INITIATES PIVOTAL PHASE 3 MOVE TRIAL FOR PALOVAROTENE IN PATIENTS WITH FIBRODYSPLASIA OSSIFICANS PROGRESSIVA.CLEMENTIA PHARMACEUTICALS INC - COMPLETION OF ENROLLMENT FOR PHASE 3 MOVE TRIAL EXPECTED BY END OF 2018.  Full Article

Clementia Pharmaceuticals qtrly loss per share ‍$1.83​
Monday, 13 Nov 2017 08:00am EST 

Nov 13 (Reuters) - Clementia Pharmaceuticals Inc ::Clementia Pharmaceuticals Inc - qtrly loss per share ‍$1.83​.Clementia Pharmaceuticals Inc- ‍as of September 30, 2017, had cash and investments of $152.2 million​.Clementia - ‍anticipates reporting preliminary results from part b open-label extension portion of phase ii study of palovarotene in fop in Q2 2018​.Clementia Pharmaceuticals Inc- on track to begin move study protocol phase iii study and enroll first patient by end of 2017​.  Full Article

Clementia Pharmaceuticals Inc shares open 22 pct above IPO price in debut
Wednesday, 2 Aug 2017 06:41am EDT 

Aug 2 (Reuters) - :Clementia Pharmaceuticals Inc shares open at $18.25 in debut on Nasdaq versus IPO price of $15.00 per share.  Full Article

Clementia announces pricing of initial public offering
Wednesday, 2 Aug 2017 06:00am EDT 

Aug 2 (Reuters) - Clementia Pharmaceuticals Inc :Clementia announces pricing of initial public offering.Says initial public offering of 8.00 million common shares priced at $15.00per share.  Full Article

Clementia Pharmaceuticals sees IPO of 7.2 mln shares priced between $13-$15/shr
Friday, 21 Jul 2017 06:13am EDT 

July 21 (Reuters) - Clementia Pharmaceuticals Inc :Clementia Pharmaceuticals Inc sees IPO of 7.2 million shares of its common shares priced between $13-$15 per share - SEC filing.Clementia Pharmaceuticals - Applied to list its common shares on Nasdaq under the symbol "CMTA".  Full Article

BRIEF-Clementia Pharmaceuticals Inc Q4 2017 Loss Per Share $0.37

* Q4 EARNINGS PER SHARE VIEW $-0.35 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: